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        Fc receptors for IgG are key players in regu-
lating innate and adaptive immunity (  1, 2  ). 
Fc    RIIb, as the only inhibitory Fc receptor for 
IgG, plays a unique role in regulating immune 
responses. It is the only Fc receptor expressed 
on B cells, where it controls the magnitude and 
persistence of the response to antigen through 
eff  ects on both mature and memory B cells and 
plasma cells (  3, 4  ). On myeloid cells, Fc    RIIb 
counteracts activation through activatory Fc re-
ceptors (such as Fc   RI, III, and IV in the mouse, 
and Fc    RI, IIa, IIIa, and IIIb in the human). 
The response of the macrophage or dendritic 
cell to complexed IgG is determined by the 
specifi  city of the diff  erent low affi   nity Fc recep-
tors for the isotypes of the IgG involved, as well 
as the relative ratio of activatory to inhibitory 
receptor expression on the cell surface (  1, 5  ). 
  Mice defi   cient in Fc    RIIb develop en-
hanced inducible immune diseases, such as col-
lagen-induced arthritis (CIA) (  6  ) and inducible 
alveolitis (  7  ), and on certain genetic back-
grounds Fc    RIIb defi  ciency can also contrib-
ute to the development of spontaneous systemic 
lupus erythematosus (SLE) (  8  ). Naturally oc-
curring polymorphisms in the promoter of 
Fc    RIIb reduce expression of the receptor in 
the mouse and are likely to contribute to spon-
taneous SLE in several mouse models (  9  –  12  ). 
Similar polymorphisms in Fc    RIIb may con-
tribute to human SLE (  13  –  15  ), and a trans-
membrane mutation associated with SLE is 
thought to do so by abolishing inhibitory func-
tion (  16, 17  ). In addition to this central role 
in controlling susceptibility to autoimmunity, 
Fc    RIIb controls survival after bacterial infec-
tion, balancing bacterial clearance and the risk 
of septic shock (  18  ), and plays a key role in de-
fense against malaria (  19  ). 
  Stringent control of Fc    RIIb expression is 
thought to be critical in determining its eff  ect 
on the immune system. IL-4 enhances Fc    RIIb 
expression and function on human macro-
phages (  20  –  22  ), whereas the same cytokine 
abolishes Fc    RIIb function and reduces ex-
pression on B cells (  23, 24  ). Expression of 
Fc    RIIb during dendritic cell maturation is also 
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  Fc    RIIb is an inhibitory Fc receptor expressed on B cells and myeloid cells. It is important 
in controlling responses to infection, and reduced expression or function predisposes to 
autoimmunity. To determine if increased expression of Fc    RIIb can modulate these processes, 
we created transgenic mice overexpressing Fc    RIIb on B cells or macrophages. Over-
expression of Fc    RIIb on B cells reduced the immunoglobulin G component of T-dependent 
immune responses, led to early resolution of collagen-induced arthritis (CIA), and reduced 
spontaneous systemic lupus erythematosus (SLE). In contrast, overexpression on macro-
phages had no effect on immune responses, CIA, or SLE but increased mortality after 
  Streptococcus pneumoniae   infection. These results help defi  ne the role of Fc    RIIb in 
immune responses, demonstrate the contrasting roles played by Fc    RIIb on B cells and 
macrophages in the control of infection and autoimmunity, and emphasize the therapeu-
tic potential for modulation of Fc    RIIb expression on B cells in infl  ammatory and auto-
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combined with the 3          enhancer to achieve B cell  –  specifi  c 
expression (  29  ). Three independent mouse lines were gen-
erated on the C57BL/6/CBA background, as identifi  ed by 
screening for a V5 tag incorporated in the construct (  Fig. 1, 
A and B  ).   The Fc    RIIb used was of the Fc    RIIb1 isoform 
and of the Ly17.1 allotype, to allow it to be diff  erentiated 
from Ly17.2, the allotype of the parental strains. Similar ex-
pression of the transgene was demonstrated in three inde-
pendently derived lines, with no eff  ect on expression of the 
parental Fc    RIIb allotype being observed (  Fig. 1 C  ). Ex-
pression on a second line is shown in Fig. S1 (available at 
http://www.jem.org/cgi/content/full/jem.20072565/DC1). 
The transgene was expressed in all B cell subsets, with high-
est expression on plasma cells, but was not expressed on 
other cell types, including follicular dendritic cells (FDCs; 
Figs. S2 and S3). The major B cell subpopulations in spleen, 
peripheral blood, and lymph nodes were of normal size in 
transgenic mice (  Fig. 1 D   and Table S1). All three founders 
showed a 2-fold increase in Fc    RIIb expression over con-
trol levels in 80  –  90% of the B cells, but interestingly, the 
remaining 10  –  20% had an approximately 10-fold increase 
in expression. This subpopulation was stable throughout 
the lifetime of the mouse, was composed predominantly of 
follicular B cells evenly distributed throughout the follicles 
on histology (Fig. S3), and had no phenotypic or functional 
features to distinguish them from the larger subpopula-
tion, apart from Fc    RIIb expression (see Supplemental dis-
cussion, available at http://www.jem.org/cgi/content/full/
jem.20072565/DC1). 
  To determine if overexpression of Fc    RIIb on B cells 
resulted in increased inhibition, B cells from B cell  –  trans-
genic (B-TG) mice were tested by several established assays 
of Fc    RIIb inhibition. Purifi  ed B cells from B-TG mice 
stimulated with anti-IgM F(ab    )  2  , which cannot recruit 
Fc    RIIb to the BCR, proliferated equally to controls. As 
expected, when Fc    RIIb was cross-linked using an intact 
anti-IgM antibody, signifi  cant suppression was seen in con-
trol mice (  30  ). This suppression was enhanced in the B-TG 
mice (  Fig. 2 A  ).   Addition of IL-4 abolished the inhibitory 
eff  ect of Fc    RIIb (  Fig. 2 A  ), as previously reported (  23  ). 
Another experiment with an Fc    RIIb-defi  cient control for 
comparison is shown in Fig. S4 A (available at http://www
.jem.org/cgi/content/full/jem.20072565/DC1). An inde-
pendent measure of proliferation, the reduction of CFSE 
with increased cell division, was used to demonstrate the 
increase in activation threshold induced by expression of the 
transgene on B cells (  Fig. 2 B  ). Finally, increased Fc    RIIb 
expression almost completely abolished the generation of 
phospho  –  extracellular signal-regulated kinase (pERK) after 
BCR cross-linking (  Fig. 2 C  ; quantifi  ed in Fig. S4, B and 
C). The induction of CD86 upon BCR cross-linking was 
also suppressed in B-TG mice but not in controls (  Fig. 2 D  ). 
Thus, we generated independent lines of mice that expressed 
approximately twofold increased Fc    RIIb on the majority 
of B cells, which resulted in an easily discernible increase in 
inhibitory function. 
modulated by cytokines, as shown by an increase in Fc    RIIb 
on mature human dendritic cells after treatment with IL-10 
and IL-13 (  25  ). Alteration of Fc    RIIb expression on plasma 
cells correlates with the ability of immune complexes to in-
duce their apoptosis (  3  ), and changes in Fc    RIIb expression 
are thought to be responsible for the therapeutic eff  ect of in-
travenous Ig ( 26  ). Thus, physiological modulation of Fc   RIIb, 
via underlying mechanisms that are incompletely understood, 
is likely to have important implications for immunity. 
  It has been shown that restoration of Fc    RIIb expression 
using a lentiviral construct could restore tolerance and pre-
vent autoimmune disease in Fc    RIIb-defi  cient mice as well 
as in strains prone to autoimmunity (  27, 28  ). These experi-
ments demonstrated that restoration of Fc    RIIb expression 
on only 30% of B cells, together with 20% of immature thy-
mocytes and 10% of macrophages, was enough to prevent 
disease. This work clearly underlines the potential for restora-
tion of Fc    RIIb to normal levels, even in a subset of cells, to 
prevent autoimmunity. Three signifi  cant questions remain. 
The fi  rst is the identity of the cell type in which Fc    RIIb 
restoration is most important. The second is whether or not 
a modest overexpression of Fc    RIIb, rather than restoration 
of defi  cient expression, is enough to alter disease progression. 
This has clear implications for the potential for modulation of 
Fc    RIIb to be therapeutically useful. The third question is 
the relative eff  ect of such a cell-specifi  c increase in Fc    RIIb 
on infection as opposed to autoimmunity, which again has 
therapeutic implications. 
  To answer these questions, we generated several lines of 
mice expressing modestly increased levels of Fc    RIIb on ei-
ther B cells or macrophages. The relatively small increases in 
expression that were generated could be demonstrated to 
enhance the inhibitory function of the receptor on both cell 
types in vitro. Overexpression on the B cell had little eff  ect 
on T-independent immune responses or on the early IgM 
response to T-dependent immunization, but it profoundly 
reduced the IgG response. Overexpression of Fc    RIIb on 
the B cell had no eff  ect on the frequency or initial course of 
CIA but resulted in early resolution, a marked reduction in 
joint destruction, and reduced levels of anti  –  collagen IgG anti-
bodies. Spontaneous SLE was also inhibited, but responses 
to bacterial infection were not. In contrast, overexpression of 
Fc    RIIb on macrophages had little eff  ect on autoimmune 
disease or on immune responses but resulted in reduced bac-
terial phagocytosis and survival in response to   Streptococcus 
pneumoniae  . Thus, increasing expression of Fc    RIIb on B 
cells and macrophages within a physiologically relevant range 
has a profound eff  ect on immune responses, as well as thera-
peutic implications for the treatment of autoimmune, infl  am-
matory, and infectious diseases. 
    RESULTS   
  Modest increases in the expression of Fc    RIIb on B cells 
enhance its inhibitory effect in vitro 
  A construct was generated in which Fc    RIIb cDNA was 
placed under the control of the human      and V  H  promoter JEM VOL. 205, April 14, 2008 
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responses (  Fig. 3 B  ). Analysis of T-dependent immune responses 
showed that the IgM response was largely intact in B-TG 
mice. Anti  –  4-hydroxyl-3-nitrophenyl acetyl (NP) IgG titers 
were normal at day 5 of the response, but there was marked 
suppression of the IgG response from day 8 onwards (  Fig. 3, 
C and D  ). Consistent with this, ELISPOT analysis showed 
little diff  erence in the short-lived IgM and IgG plasmablast 
  The predominant effect of Fc    RIIb overexpression 
is to suppress the IgG component of T-dependent 
immune responses 
  Titers of total serum IgG, but not IgM, were reduced in B-TG 
mice (  Fig. 3 A  ).   To investigate this, we studied the antibody 
responses to a range of model antigens. Fc    RIIb overexpres-
sion had surprisingly little eff  ect on T-independent immune 
    Figure 1.         Generation of B-TG mice overexpressing Fc    RIIb.   (A) The construct used to direct B cell  –  specifi  c expression of transgenic Fc   RIIb. 
(B) Western blot, using a V5-specifi  c antibody, of splenic B cell (CD43    ve) and non  –  B cell (CD43+ve) populations from B-TG and B-NTG mice. (C) Flow 
cytometric analysis of transgene expression on B220  +   splenic cells (as shown in the gated populations on the dot plots) from B-NTG and B-TG mice. His-
tograms represent either 2.4G2 (which recognizes all Fc    RIIb on B cells), Ly17.2 (endogenous Fc   RIIb-specifi  c), or Ly17.1 (transgenic Fc   RIIb-specifi  c) 
expression (shaded histogram = isotype control). No detectable transgene expression was demonstrated on non  –  B cells (Fig. S2). (D) The proportions of 
B cell subsets analyzed were normal in B-TG mice. Splenocytes were stained with anti-IgM, -IgD, -CD21, and -CD23 and assessed by fl  ow cytometry (per-
centages of gated populations are shown; see also Table S1). B  –  D are representative of at least three independent experiments.   886 DISTINCT CELL-SPECIFIC CONTROL OF AUTOIMMUNITY AND INFECTION BY F  C   RII B   | Brownlie et al.
lines, as demonstrated by Western blotting for the V5 tag 
incorporated in the construct (  Fig. 4, A and B  ).   Expression 
was confi  rmed on peritoneal macrophages (  Fig. 4 C  ), as 
well as on macrophages from bone marrow and spleen, and 
on peritoneal macrophages from an independent strain (Fig. 
S5, available at http://www.jem.org/cgi/content/full/jem
.20072565/DC1). Expression was not seen on dendritic cells, 
B cells, FDCs, or other cell types (Figs. S5 and S6). Macro-
phage numbers in all of these organs were normal (Table S2). 
To determine if the macrophage transgene was functional, Fc 
receptor  –  triggered calcium signaling, known to be inhibited 
by Fc    RIIb (  33  ), was assessed in Fura2-loaded peritoneal 
macrophages. Although there were no diff  erences in peak 
intracellular calcium signal after Fc receptor aggregation, pla-
teau calcium levels were signifi  cantly reduced in cells from 
transgenic mice (  Fig. 4 D  ). Phosphorylation of ERK was also 
measured in peritoneal macrophages as a read out of activa-
tion after Fc receptor cross-linking. ERK phosphorylation 
was suppressed by expression of the transgene, in contrast to 
controls and to the marked increase seen in Fc    RIIb-defi  -
cient mice (  Fig. 4 E  ). Thus, a relatively modest increase in 
response (  3  ). In response to secondary immunization, both 
IgM and IgG levels were reduced in B-TG mice compared 
with controls (  Fig. 3 C  ), and we have previously described 
reduced bone marrow plasma cell accumulation and persis-
tence in these mice (  3  ). These results demonstrate that de-
spite the fact that Fc   RIIb cross-linking profoundly suppresses 
proliferation of IgM  +   B cells in vitro (  Fig. 2, A and B  ; and 
Fig. S4 A) (  4, 30  ), IgM production is not infl  uenced in the 
primary immune response in vivo. Affi   nity maturation was 
ascertained by NP  2  /NP  12   ELISA (  31  ) after secondary immu-
nization. There was a signifi  cant increase in the ratio of anti-
NP  2   to anti-NP  12   IgG in B-TG mice (  Fig. 3 E  ), consistent 
with more stringent selection of high affi   nity B cells when 
Fc    RIIb is increased. 
  Increased macrophage inhibition by transgenic expression 
of Fc    RIIb 
  Macrophage-specifi   c expression of Fc    RIIb was achieved 
using a construct in which Fc    RIIb2 mRNA was placed un-
der the control of the human CD68 promoter (  32  ). This re-
sulted in macrophage-specifi  c expression in two independent 
    Figure 2.         Fc-mediated proliferation, ERK phosphorylation, and CD86 expression are suppressed in B-TG B cells.   (A) Proliferation of B cells from 
B-TG and B-NTG mice after 72 h of activation with either intact anti-IgM or anti-IgM F(ab   ) 2   antibodies, with and without IL-4, assessed by [  3 H]thymidine 
incorporation. (B) CFSE staining of B cells from B-NTG and B-TG mice after activation with varying concentrations of either intact anti-IgM or anti-IgM 
F(ab   ) 2   antibodies for 120 h before analysis by fl  ow cytometry. (C) Assessment of ERK phosphorylation by intracellular fl  ow cytometry after B cell activa-
tion for 1 min with either anti-IgM intact or anti-IgM F(ab   ) 2   antibodies (PMA = positive control; dashed lines indicate the gate used to quantify the ex-
tent of pERK, as shown in Fig. S4). (D) CD86 expression on B-NTG and B-TG B cells after activation with anti-IgM intact or anti-IgM F(ab   ) 2   molecules 
for 48 h, analyzed by fl  ow cytometry. Error bars in A represent SD of triplicate wells from three pooled mice; error bars in D represent SD of three 
mice. p-values were calculated by the Students   t   test. A is representative of three independent experiments; B, C, and D are representative of two inde-
pendent experiments.     JEM VOL. 205, April 14, 2008 
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    Figure 3.         Overexpression of Fc    RIIb on B cells suppresses the T-dependent IgG immune response.   (A) Total IgG and IgM titers were measured in serum from 
naive B-NTG and B-TG mice. Values were calculated from a standard curve of known Ig concentration. Mice were immunized intraperitoneally with NP-haptenated 
carriers in alum, and antibody responses were assessed by ELISA. B-TG and B-NTG mice were injected with either T-independent (B, NP-fi  coll) or T-dependent 
(C, NP-CGG) antigens and boosted on day 40 with NP-CGG alone or NP-KLH (D). Serum was then assessed for total anti-NP  12   IgM and IgG production at various time 
points after immunization. (E) The affi  nity of anti-NP IgG was assessed by calculating the ratio of anti-NP  2   (high  affi  nity)/anti-NP  12   (total) IgG (NP  2 /NP 12  ) by ELISA 
from serum obtained from B-NTG and B-TG mice immunized with NP-KLH on day 0, boosted on day 40, and bled on day 49. Each symbol shows data from a single 
mouse, and the horizontal lines represent the mean. p-values were calculated using the Student  ’  s   t   test. A  –  C are representative of three independent experiments.    888 DISTINCT CELL-SPECIFIC CONTROL OF AUTOIMMUNITY AND INFECTION BY F  C   RII B   | Brownlie et al.
fi  ed chick type II collagen (CII) immunization protocol (  34  ). 
B-TG mice showed the same incidence of CIA as controls, 
and the time of onset and early course of the infl  ammation 
were indistinguishable (  Fig. 5, A and B  ).   In contrast in the B-
TG mice, however, joint infl  ammation resolved quickly after 
disease onset, and this resolution was sustained. Consistent 
with this, there was a reduction in joint damage, as determined 
by histology at day 74 in B-TG mice compared with controls 
(  Fig. 5 G  ). IgG anti  –  collagen antibodies are important in the 
pathogenesis of CIA (  35, 36  ) and are suppressed in B-TG mice, 
providing a possible mechanism for the reduction in infl  amma-
tion (  Fig. 5 E  ). All IgG isotypes were equally suppressed in the 
B-TG mice (Fig. S8, available at http://www.jem.org/cgi/
content/full/jem.20072565/DC1), but IgM was not aff  ected 
(  Fig. 5 E  ). In contrast, no substantial diff  erence in incidence, 
disease course, or antibody production was seen in several ex-
periments in the M-TG mice (  Fig. 5, C, D, and F  ), whereas 
there was a nonsignifi  cant trend toward increased histological 
joint damage, perhaps because of a failure of macrophage re-
modeling and/or immune complex clearance (  Fig. 5 H  ). 
Fc    RIIb expression on macrophages resulted in a signifi  cant 
increase in inhibitory eff  ect in vitro. 
  Fc    RIIb overexpression on macrophages does not infl  uence 
the T-dependent immune response 
  Macrophage-transgenic (M-TG) mice were immunized with 
two T-independent antigens (NP-dextran and NP-LPS), and 
although a possible trend toward a reduction in IgG production 
was seen at later time points, initial responses to these anti-
gens were not signifi  cantly diff  erent from control mice (Fig. S7, 
A and B, available at http://www.jem.org/cgi/content/full/
jem.20072565/DC1). Furthermore, the T-dependent re-
sponse in M-TG mice was indistinguishable from macrophage-
nontransgenic (M-NTG) controls (Fig. S7 C). 
  Increased Fc    RIIb expression on B cells, 
but not macrophages, modifi  es the course of CIA 
and spontaneous lupus 
  CIA is a widely used model of infl  ammatory joint disease. It 
can be induced on the C57BL/6 background using a modi-
    Figure 4.         Generation of M-TG mice overexpressing functional Fc    RIIb.   (A) The construct used to direct macrophage-specifi  c expression of trans-
genic Fc    RIIb. (B) Western blot, using a V5-specifi  c antibody, of peritoneal macrophages from M-TG (lines 1 and 2) and M-NTG mice to detect the pres-
ence of the V5-tagged transgene. All further experiments use line 2. (B) Flow cytometric analysis of transgene expression on F4/80  + CD11b +   peritoneal 
macrophages (gated population shown on dot plot) from M-NTG and M-TG mice. Histograms represent either 2.4G2 (recognizes all Fc    RIIb, III, and IV), 
Ly17.2 (endogenous Fc   RIIb-specifi  c), or Ly17.1 (transgenic Fc   RIIb-specifi  c) expression (shaded histogram = isotype control). No detectable transgene 
expression was demonstrated on other cell types (Figs. S5 and S6). (D) Intracellular calcium measurements in M-NTG and M-TG peritoneal macrophages 
after Fc    RIIb cross-linking (arrow). Inset shows mean peak and plateau calcium responses. (E) Measurements of ERK phosphorylation in peritoneal mac-
rophages from M-NTG, M-TG, and Fc   RIIb    /     mice after Fc    RIIb cross-linking. The percent increase in pERK-positive cells after stimulation is shown. 
Error bars represent the SD of triplicate samples from three or four pooled mice. p-values were calculated using the Student  ’  s   t   test. D and E are repre-
sentative of two and three independent experiments, respectively.     JEM VOL. 205, April 14, 2008 
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uria and autoantibodies (  Fig. 6, C, E, and F  ). In contrast, no 
signifi  cant diff  erences in disease progression were observed in 
the M-TG mice (  Fig. 6, B, D, and G  ). 
  Fc    RIIb overexpression on macrophages, but not B cells, 
suppresses responses to bacterial infection 
  In view of the eff  ect of Fc    RIIb on bacterial infection in 
Fc    RIIb-defi  cient mice (  18  ), we examined the response 
of the transgenic mice to pneumococcal infection. In the 
B-TG mice,   “  natural  ”   IgM antibody titers against pneu-
mococcus were normal, and IgG was only slightly reduced 
(Fig. S9, available at http://www.jem.org/cgi/content/full/
jem.20072565/DC1). In addition, phagocytosis of opsonized 
bacteria in vitro by peritoneal macrophages was also normal 
(unpublished data). Consistent with these fi  ndings, no eff  ect 
  MRL/  lpr   mice develop a spontaneous autoimmune disease 
resembling human SLE. The disease is characterized by the 
development of antinuclear antibodies (ANA), glomerulone-
phritis, and infl  ammatory skin lesions (  37  ). Although other 
cells play their role, the importance of B cells is highlighted 
by complete abrogation of disease in B cell  –  defi  cient MRL/
  lpr   mice (  38  ). B-TG and M-TG mice were crossed onto the 
MRL/  lpr   background (Table S3, available at http://www
.jem.org/cgi/content/full/jem.20072565/DC1) and assessed 
for the development of autoimmunity. There was a striking 
reduction in mortality in the B-TG MRL/  lpr   mice. All B 
cell  –  nontransgenic (B-NTG) MRL/  lpr   mice were moribund 
by 34 wk of age, compared with only 14% of B-TG MRL/
  lpr   mice (  Fig. 6 A  ).   Consistent with this protection from 
  disease, B-TG mice had signifi  cantly lower levels of protein-
    Figure 5.         Suppressed severity of CIA in B-TG but not M-TG mice.   (A) Cumulative arthritis incidence and (B) mean clinical scores (  ±  SEM) for B-TG 
(  n   = 14) compared with B-NTG (  n   = 13) mice over 74 d. (C) Cumulative arthritis incidence and (D) mean clinical scores (  ±  SEM) for M-TG (  n   = 32) compared 
with M-NTG (  n   = 38) mice (data represent three independent experiments combined). p-values for clinical scores were calculated using the unpaired 
Student ’ s   t   test. *, P   <   0.05; no signifi  cant differences were detected in the incidence by     2   analysis. (E and F) Circulating levels of CII-specifi  c antibody were 
determined in individual sera by ELISA. Results show mean total IgG and IgM levels (  ±  SEM) as arbitrary units per milliliter (levels of IgG isotypes are shown 
in Fig. S8). (G and H) At the end of the study, paws were processed for histology and scored blinded for signs of arthritis. Data represent mean   ±   SEM.     890 DISTINCT CELL-SPECIFIC CONTROL OF AUTOIMMUNITY AND INFECTION BY F  C   RII B   | Brownlie et al.
this receptor on both cell types. The degree of expression dif-
ference seen in both transgenic mice was less than the diff  er-
ence that can be induced by cytokine treatment, for example 
(  20  –  24  ), and was thus likely to fall within the physiological 
range of expression of the receptor. Nonetheless there was a 
profound increase in inhibitory eff  ect, as measured by several 
independent in vitro assays. This implies that the physio-
logical variation in Fc    RIIb expression seen in humans and 
mice with Fc    RIIb promoter polymorphisms, and the changes 
in expression that can be induced by cytokines, are very likely 
to have substantial eff  ects on Fc    RIIb function. 
  The eff  ect of Fc    RIIb on B cell proliferation has tradi-
tionally been measured in vitro by cross-linking surface IgM 
on mortality was seen in the B-TG mice when they were 
challenged with pneumococcus (  Fig. 7 A  ).   In contrast, al-
though natural antibody levels were normal (Fig. S9), M-TG 
mice showed a marked reduction in their ability to phagocy-
tose opsonized pneumococci in vitro (  Fig. 7 B  ). In keeping 
with this, there was a modest but consistent and signifi  cant 
reduction in mortality in M-TG mice after challenge with 
pneumococcus given either intraperitoneally or intranasally 
(  Fig. 7, C  –  E  ). 
    DISCUSSION   
  Enhancing the expression of Fc    RIIb on both B cells and 
macrophages was shown to increase the inhibitory eff  ect of 
    Figure 6.         Protection from lupus in B-TG mice.   B-TG and M-TG mice were crossed with MRL/  lpr   mice and spontaneous lupus was monitored for up 
to 40 wk of age. (A and B) Survival rates are shown for groups of B-TG (  n   = 8), B-NTG (  n   = 10), M-TG (  n   = 12), and M-NTG (  n   = 21) mice. (C and D) Pro-
teinuria levels were recorded weekly in all mice throughout the study. Data are presented as mean   ±   SEM. p-values were calculated using the unpaired 
Student ’ s   t   test. *, P   <   0.05. (E) All mice were screened for serum levels of ANA at 20  –  24 wk of age using Hep-2 slides, and representative results for 
B-NTG and B-TG mice are shown. (F and G) Serum from each mouse was analyzed for anti-dsDNA IgG. Each symbol represents an individual mouse. Error 
bars represent SEM. p-values were calculated using the     2   test (A and B) and the Student  ’  s   t   test (all other values).     JEM VOL. 205, April 14, 2008 
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suggests two possible explanations. The fi  rst is that Fc    RIIb-
mediated suppression of B cell responses requires the production 
of an adequate titer of antigen-specifi  c IgG that can cross-
link Fc    RIIb. Such cross-linking may not be achieved in 
T-independent responses, as they are dominated by IgG3 (  39  ), 
which has extremely low affi   nity for Fc    RIIb (  5  ). The rela-
tive lack of eff  ect on the T-dependent IgM response could 
refl  ect the fact that most IgM is made within the fi  rst week 
of immunization, before IgG rises. This model is also con-
sistent with the initial normal production of anti-NP IgG at 
day 5, with mild diff  erences beginning to be seen at day 8, 
presumably as anti-NP IgG titers have risen suffi   ciently to 
allow Fc    RIIb cross-linking to occur. An alternative or ad-
ditional explanation is that Fc    RIIb-mediated suppression 
in vivo requires substantial cross-linking only achieved on the 
surface of the FDC. This model would predict that suppres-
sion would only occur once the germinal center (GC) reac-
tion had become important, thereby accounting for the lack 
of eff  ect on T-independent responses, where GCs play at 
most a minor role. In T-dependent responses, it would 
explain both the lack of eff  ect on IgM (most early IgM is 
made by plasmablasts of the extrafollicular foci, and GCs pre-
dominantly contain isotype-switched B cells) and on early 
IgG, made before GC formation has become important (usu-
ally estimated to be from 6 d onwards) (  40  ). The low affi   nity 
plasmablast response (both IgM and IgG) is controlled inde-
pendently of Fc    RIIb, as we have previously shown using 
Fc    RIIb      /      mice (  3  ). Thus, overexpression of Fc    RIIb 
has helped defi  ne the precise stage of the immune response 
at which Fc    RIIb-mediated suppression is important, and 
suggests the need for further work to elucidate the mecha-
nism underlying this. In addition, we have presented data 
that suggest increased stringency of affi   nity maturation in B-TG 
mice. This suggests that an increased B cell activation thresh-
old controls affi   nity maturation. Currently, we are testing this 
at the single-cell level, as described previously (  31  ). 
  The Fc    RIIb-defi  cient mouse was made using a C57BL/
6/129 embryonic stem cell line (  4  ). When other genes in the 
same region of distal chromosome 1 have been deleted, they 
have also shown an autoimmune phenotype (e.g., comple-
ment receptor 1/2 [  41  ], decay accelerating factor CD55 [  42  ], 
and serum amyloid P component [  43  ]), much of which has 
subsequently been found to be caused by the adjacent region 
of 129 origin rather than to the gene deletion itself (  44, 45  ). 
The eff  ect of our transgene in suppressing autoimmunity is 
clearly independent of this 129 region. This confi  rms that 
Fc    RIIb plays a role in controlling autoimmunity and sug-
gests that the autoimmune phenotype of the Fc    RIIb-defi  -
cient mouse is not an artifact of 129 contamination. 
  Antibodies have long been known to be important in the 
pathogenesis of CIA. Mice defi  cient in B cells are totally re-
sistant to CIA induction (  34  ), and it is possible to induce ar-
thritis using anti-CII antibodies (  36, 46  ). Despite B-TG mice 
having decreased anti  –  collagen antibodies, the incidence and 
initial course of CIA was unchanged. Rather, the suppression 
of anti  –  collagen antibodies by transgenic Fc    RIIb results in 
with or without ligation of Fc    RIIb. This has profound ef-
fects on the activation threshold of B cells, as shown in sev-
eral previous studies (  4, 30  ), as well as in   Fig. 2  . It is therefore 
interesting that the overexpression of Fc    RIIb on B cells has 
little eff  ect on T-independent responses or on IgM responses 
to T-dependent antigens. This, together with the fact that 
IgG was only markedly aff  ected from day 8 after immunization, 
    Figure 7.         M-TG mice are more susceptible to pneumococcal infec-
tion.   Survival after   S. pneumoniae   infection. (A) Groups of B-TG (  n   =  8) 
and B-NTG (  n   = 11) mice were inoculated intraperitoneally with 2   ×   10  4  
CFU   S. pneumoniae   type 2 (D39). (B) Peritoneal macrophages were incu-
bated with Alexa Fluor 488  –  labeled   S. pneumoniae   either unopsonized or 
opsonized with heat-inactivated immune serum, followed by fl  ow cyto-
metric analysis. Antibody-dependent phagocytosis is expressed as the 
percentage of Alexa Fluor 488  +   cells relative to the nonopsonized sample. 
Error bars represent SD of three mice per group and are representative of 
four independent experiments. (C) Groups of M-TG (  n   = 8) and M-NTG 
(  n   = 9) mice were inoculated intraperitoneally with 10  2   CFU   S. pneumoniae  
type 2 (D39). A signifi  cant reduction in survival was observed for the 
M-TG mice (P = 0.02). (D) Graphical representation of data pooled from 
fi  ve separate infection experiments (including C) using various doses of   S. 
pneumoniae   (3   ×   10 1 ,  10 2 ,  10 4 ,  10 6  , and 10  7  ). Data represent mean   ±   SEM. 
The kinetics differ depending on dose; to normalize for this, data are 
shown as survival at the time point before 100% mortality of the M-TG 
mice (indicated by the gray box in C). (E) Intranasal infection of M-NTG 
(  n   = 11) and M-TG (  n   = 10) mice with 2   ×   10  6   CFU   S. pneumoniae   type  2 
(D39). p-values were calculated using the Student  ’  s   t   test (B and D) and 
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receptor expression on B cells might play in infl  ammatory and 
autoimmune disease. It has also defi  ned the role of Fc    RIIb in 
suppressing the T-dependent immune response, and has shown 
that increased expression on macrophages reduces survival after 
bacterial infection, demonstrating the importance of macro-
phage Fc    RIIb in the control of infection and emphasizing 
the importance of careful cell-specifi  c targeting in thera-
peutic modulation. 
  MATERIALS AND METHODS 
  Mice 
  C57BL/6 Fc    RIIb      /      mice (  4  ) were provided by J. Ravetch and S. Bolland 
(The Rockefeller University, New York, NY). MRL/  lpr   mice were purchased 
from Harlan. All other mice were obtained from Charles River Laboratories. 
All experiments were performed according to the regulations of the UK Home 
Offi   ce Scientifi  c Procedures Act (1986). The animal experiments were ap-
proved by the UK Home Offi   ce. 
  Generation of B-TG and M-TG mice overexpressing Fc    RIIb.     To di-
rect B cell  –  specifi  c expression of Fc    RIIb, we used a construct containing a 
V  H   promoter, the IgH intron enhancer, and the Ig     3     enhancer, which was a 
kind gift from T. Tsubata (Tokyo Medical and Dental University, Tokyo, 
Japan) (  29  ). To direct macrophage-specifi  c expression of Fc    RIIb, we used a 
construct containing the human CD68 (hCD68) promoter, as previously de-
scribed (  32  ). We introduced the mouse Fc    RIIb.1 (Ly17.1 allotype) tagged 
with both the V5 and Hisx6 epitopes into these constructs. Transgenic mice 
were established by injecting the DNA fragment containing the tagged 
Fc    RIIb cDNA and the respective promoters, or enhancers in the case of the 
B cell construct, into CBA-fertilized eggs. The presence of transgene was iden-
tifi  ed by tail DNA PCR assays (B-TG primers: 5      –  3    , 5    -TTCTCGGCTCT-
GTGAATGACA-3    , and 3      –  5    , 5    -CAGCCCTCTCTTGGAAAGGAG-3    ; 
M-TG primers: 5      –  3    , 5    -CATAGCTGGAGGAACAAACTACTGAAC-3    , 
and 3      –  5    , 5    -GTAGAATCG AGACCGAGGAGAGG-3    ). Transgenic off  -
spring were backcrossed with C57BL/6 mice for at least seven generations. 
Transgenic mice were crossed to MRL/  lpr   mice for at least fi  ve generations 
using a marker-selected backcrossing method (Table S3) predicted to result in 
  >  99% MRL genetic background by N5 (  53  ). 
  B cell purifi  cation and stimulation 
  Splenic B cells were negatively selected by magnetic cell purifi  cation using 
anti-CD43 beads (Miltenyi Biotec) to   >  90% purity. 2   ×   10  6   cells/ml were 
usually cultured in 24-well fl  at-bottom plates (Corning Inc.) in RPMI 1640 
(Sigma-Aldrich) and 10% FCS (Invitrogen), and were stimulated with either 
goat anti  –  mouse IgM   μ   chain  –  specifi  c F(ab    )  2   or intact IgG at 10   μ  g/ml, un-
less otherwise stated in the fi  gures (Jackson ImmunoResearch Laboratories). 
IL-4 added to these cultures was used at 10 ng/ml (PeproTech). PMA was 
used at 1 ng/ml. 
  Peritoneal macrophages, splenic dendritic cells, and bone marrow  –
  derived macrophages (BMDMs) and dendritic cells (BMDCs) 
  Resident peritoneal macrophages were harvested from mice by peritoneal 
lavage using 5% BSA in PBS. Splenic dendritic cells were isolated from 
spleens that were gently disrupted between glass slides and cut up into 
5 ml of 2% BSA/PBS containing 1 mg/ml collagenase (Worthington) and 
0.1 mg/ml DNase I (Roche). Suspensions were kept at room temperature 
for 30 min with regular pipetting before RBC lysis using ammonium 
chloride. Bone marrow cells were fl  ushed with cold RPMI 1640 contain-
ing 10% FCS from the dissected tibias and femurs of NTG and TG mice. 
RBCs were lysed with ammonium chloride, and the remaining cells were 
washed three times. 2   ×   10  6   bone marrow cells per well were seeded into 
six-well tissue culture plates. Cells were cultured for 7 d in the presence 
of 4 ng/ml of recombinant M-CSF (PeproTech) to generate BMDMs, or 
in the presence of 20 ng/ml of recombinant GM-CSF (PeproTech) to gen-
erate BMDCs. 
early disease resolution and an improved long-term outcome. 
This shows that relatively modest modulation of Fc    RIIb 
expression can have a critical eff  ect on infl  ammatory arthritis 
despite not aff  ecting onset. If it was possible to achieve such 
a change in expression pharmacologically, it would have clear 
therapeutic implications, particularly in humans, where pre-
emptive therapy is rarely possible and patients present with 
established disease. The fact that overexpression of Fc    RIIb 
on B cells also markedly reduces spontaneous SLE pro-
vides further encouragement that this avenue may be thera-
peutically useful. The eff  ect of Fc    RIIb overexpression on 
the macrophage, in contrast, had little eff  ect on either CIA 
or spontaneous SLE. Overall, these results indicate that the 
B cell, rather than the macrophage, should be the primary 
target of therapeutic modulation of Fc    RIIb in infl  amma-
tory disease. 
  The eff  ect of overexpressing Fc    RIIb on autoimmunity 
will be infl  uenced by the fact that diff  erent Fc receptors selec-
tively engage IgG subclasses with varying affi   nities (  1, 47  –  49  ). 
Fc    RI binds IgG2a with high affi   nity  and  Fc    RIV binds 
IgG2a and IgG2b with intermediate affi   nity, whereas Fc    RIIb 
and Fc    RIII bind IgG2a, IgG2b, and IgG1. Moreover, the 
affi   nity with which Fc    RIV binds IgG2a or IgG2b is at least 
twofold higher than Fc    RIIb and between 20 and 40 times 
higher than Fc    RIII (  50  ). Thus, IgG2a and IgG2b immune 
complexes would preferentially bind to Fc    RIV, and little 
eff  ect of Fc    RIIb co  –  cross-linking may be seen. In contrast, 
immune complexes containing IgG1 would more likely bind 
Fc    RIIb and, thus, induce its inhibitory eff  ect. CIA is pre-
dominantly associated with IgG2a anti  –  collagen antibodies 
(Fig. S5) (  51  ), and in SLE, autoantibodies of the IgG2a sub-
class are also dominant (  52  ). Thus, in the M-TG mouse, im-
mune complexes are likely to engage Fc    RIV in preference 
to Fc   RIIb, which might explain the lack of eff  ect of Fc   RIIb 
overexpression on macrophages in both CIA and SLE. 
  Natural antibody levels against pneumococcus were simi-
lar to controls in both B-TG and M-TG mice, consistent 
with the fact that they were also normal in Fc    RIIb-defi  cient 
mice (  18  ). Given that pneumococcal challenge results in very 
rapid onset of illness before an IgG response can be initiated, it 
is thus not surprising that survival was normal in the B-TG 
mice. In M-TG mice, however, where reduced phagocytosis 
of pneumococcus could be demonstrated in vitro, there was a 
signifi  cant reduction in survival. Although of a similar magni-
tude, this eff  ect is the converse of that seen with the Fc    RIIb-
defi  cient mouse (  18  ), thus underlining the likelihood that the 
latter observation was caused by Fc    RIIb defi  ciency on the 
macrophage. This highlights the importance of Fc    RIIb in 
controlling initial bacterial clearance in infection. It focuses 
attention on the potential for manipulating expression of the 
receptor on macrophages to either be useful in therapy, perhaps 
in the treatment of septic shock (  9, 18  ), or to be responsible for 
adverse eff  ects if expression is increased in the treatment of in-
fl  ammatory disease. 
  Cell-specifi  c overexpression of Fc    RIIb on B cells and 
macrophages highlights the role that therapeutic modulation of JEM VOL. 205, April 14, 2008 
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  T-independent and T-dependent immunization 
  Samples of preimmune sera were taken before the initial immunization. 
Groups of mice were immunized intraperitoneally with 100   μ  g NP-fi  coll, 
NP-dextran, NP-LPS, NP  –  chicken      globulin (CGG), or NP-KLH (Bio-
search Technologies) emulsifi  ed in alum (Alu-Gel-S; Serva Electrophoresis). 
Samples of blood from tail veins were taken at various time points after im-
munization. For secondary responses, mice received a further 100   μ  g NP-
CGG or -KLH/alum on day 28 or 40. Tail bleeds were taken on day 44. 
  ELISA 
  For analysis of serum anti-NP antibodies, plates (Nunc Maxisorp; Thermo 
Fisher Scientifi  c) were coated with 5   μ  g/ml NP  12  - or NP  2  -BSA (Biosearch 
Technologies) overnight (the NP  2  /NP  12   ratio was used to assess affi   nity 
maturation). Plates were blocked by the addition of PBS/1% BSA for 1 h. 
Serial dilutions of sera were added. To detect specifi  c antibody isotypes, 
HRP-conjugated secondary antibodies were used (SouthernBiotech). EC  50   
values were calculated by nonlinear regression analysis using Prism software 
(Microsoft). Standard curves were constructed from the pooled sera of NP-
hyperimmunized mice. 
  Serum IgM, IgG, IgG2a, IgG2b, IgG1, and IgG3 were assayed using 
paired capture and HRP-conjugated antibodies (SouthernBiotech), and a 
standard curve of known concentration of the same mouse Ig isotype. 
  Anti-dsDNA antibody levels were measured by ELISA, as previously 
described (  55  ). In brief, 96-well ELISA plates were coated with 5   μ  g/ml of 
calf thymus dsDNA (Sigma-Aldrich) in sodium salt citrate buff  er at 37  °  C 
overnight. Plates were washed with PBS/0.05% Tween 20 and blocked with 
1% BSA/PBS, and sera were added in serial dilutions starting at 1:100 and 
incubated for at least 1 h at room temperature. After a further wash, HRP-
conjugated goat anti  –  mouse IgG was added. Pooled MRL/  lpr   serum was 
used as a standard curve. 
  Levels of antiphosphorylcholine (anti-PC) antibodies were measured by 
ELISA, as previously described (  18  ). In brief, 96-well Maxisorp microtiter 
plates were coated with 20   μ  g/ml PC conjugated to BSA (Biosearch Tech-
nologies) overnight at 4  °  C. Plates were blocked with PBS/10% FCS and 
washed, and dilutions of serum in PBS/0.05% Tween 20 were added for 2 h. 
A positive control (pooled serum from mice immunization with Pneumovax 
II; Aventis-Pasteur MSD) was included on each plate. Plates were revealed 
with HRP-conjugated goat anti  –  mouse IgM and IgG. 
  CIA 
  The protocol followed to induce CIA in C57BL/6 mice was reported by 
Campbell et al. (  34  ). CFA was prepared by grinding 100 mg heat-killed   Myco-
bacterium tuberculosis   (H37Ra; Difco Laboratories) in 20 ml of incomplete 
Freund  ’  s adjuvant (Sigma-Aldrich). An emulsion was formed by dissolving 
2 mg/ml of chick CII (Sigma-Aldrich) overnight at 4  °  C in 10 mM of acetic 
acid and combining it with an equal volume of CFA. Mice were injected with 
100   μ  l CII/CFA intradermally into the base of the tail. The same injection was 
repeated at day 21. Animals were assessed for redness and swelling of limbs, and 
a clinical score was allocated for each mouse two to three times per week for up 
to 86 d. The maximum score per mouse was 12. At the end of the experiment, 
the paws of the mice were removed, fi  xed, decalcifi  ed, and paraffi   n embedded. 
5-  μ  m sections were stained with hematoxylin and eosin and examined for his-
tological changes of infl  ammation, pannus formation, and cartilage and bone 
damage. ELISA for antibody to CII was performed as previously described (  34  ). 
HRP-conjugated goat anti  –  mouse IgM, IgG, IgG1, IgG2a, IgG2b, or IgG3 
(SouthernBiotech) detection antibodies were used. Standard curves were con-
structed from the pooled sera of CII-hyperimmunized DBA/1 mice. 
  Proteinuria measurements 
  Urine protein levels were measured with Multistix 10 SG (Bayer) and scored 
as follows: 0 = negative; 0.5 = trace; 1 = 30 mg/dl; 2 = 100 mg/dl; 3 = 300 
mg/dl; and 4 = 2,000 mg/dl or more. 
  ANA test 
  ANAs were examined using a commercial indirect fl  uorescent antibody assay 
(ANA Hep-2 slide; Cambridge Life Sciences) according to the manufacturer  ’  s 
  Flow cytometric analysis 
  Cells were stained with combinations of anti-Fc    RII/III  –  FITC and 
  –  biotin (2.4G2), anti-Fc    RII (Ly17.1-FITC and Ly17.2-biotin; Cedarlane), 
CD19-FITC (1D3), CD22-FITC (Cy34.1), B220-allophycocyanin (APC), 
B220-biotin, B220-PE (RA3-6B2), IgM-FITC (R6-60.2), I-A  b    –  FITC 
(25-9-17), IgD-PE (11-26; SouthernBiotech), CD21/CD35-FITC (7G6), 
CD23-PE (B3B4), CD86-PE (GL1), CD3-PE (17A2), CD4-PerCP 
(GK1.5), CD8-biotin (RA3-6B2), CD43-biotin (S7), F4/80-RPE 
(MCA497PE; Serotech), CD11b-APC (M1/70), CD11c-APC, CD11c-
PE (HL3), or isotype controls (all antibodies were purchased from BD 
Biosciences unless otherwise stated). Biotinylated antibodies were cross-
linked with streptavidin conjugated to FITC, PerCP, or APC (BD Biosci-
ences). 1% normal rat serum was used to block nonspecifi  c  antibody 
binding. 7-amino-actinomycin D (Invitrogen) was used to exclude dead 
cells. Cells were analyzed using a fl  ow cytometer (FACSCalibur; BD Bio-
sciences) and FCS Press software (provided by R. Hicks, University of 
Cambridge, Cambridge, UK). 
  Immunofl  uorescence microscopy 
  Spleens from B-NTG and B-TG mice were sectioned 7   μ  m thick using a 
cryostat and left to dry overnight. Sections were fi  xed in cold acetone for 
5 min and blocked for 1 h with 5% BSA/PBS and 5% normal goat or rat 
serum before staining. Sections were stained in blocking medium at room 
temperature with 2.4G2-FITC and B220-biotin for 1 h, and then stained 
with streptavidin  –  Alexa Fluor 546 for 1 h. For FDC staining, sections 
were initially stained with rat anti  –  mouse FDCM-1 (BD Biosciences) and 
detected with goat anti  –  rat IgG Alexa Fluor 555 (absorbed against mouse 
Ig; Invitrogen). Sections were then stained with 2.4G2-FITC, B220-bio-
tin, and goat anti  –  mouse IgG Alexa Fluor 633 (highly cross absorbed; 
Invitrogen), followed by streptavidin  –  Pacifi  c blue (Invitrogen). Alternatively, 
spleens from M-NTG and M-TG mice were sectioned and stained with 
FDCM-1, as described, and then stained with 2.4G2-FITC and B220  –  Alexa 
Fluor 647 (BioLegend). Vectorshield hardset was used to mount sections 
before analysis by confocal microscopy. 
  Intracellular signaling measurements 
  Purifi  ed B cells were stimulated with either goat anti  –  mouse IgM   μ   chain  –
  specifi  c F(ab    )  2   or intact IgG for between 1 and 30 min. Peritoneal macro-
phages were stimulated by incubating cells with 2.4G2-biotin before 
cross-linking with streptavidin for between 1 and 30 min (Dako). To deter-
mine the extent of ERK phosphorylation, stimulated cells were fi  xed in 4% 
formaldehyde for 10 min at 37  °  C and permeabilized by adding 100% metha-
nol for 30 min at 4  °  C. Samples were incubated with phospho-p44/42 Map 
kinase (Thr202/Tyr204) antibody (Cell Signaling Technology) for 1 h at 
room temperature, washed, and stained with an Alexa Fluor 488 F(ab    )  2   
fragment of goat anti  –  rabbit IgG (H+L; Invitrogen). Cells were analyzed by 
fl  ow cytometry. To determine intracellular calcium fl  ux, macrophages were 
loaded with Fura2-AM ester before activation and measured by cuvette fl  uo-
rimetry, as previously described (  54  ). 
  Proliferation assays 
  2   ×   10  6   purifi  ed B cells/ml were stimulated with anti-IgM   μ   chain  –  specifi  c 
F(ab    )  2   or intact antibody for 72 h. 0.5   μ  Ci tritiated [  3  H]thymidine (GE 
Healthcare) was added for the last 8 h of culture, and incorporation was de-
termined using a scintillation counter (PerkinElmer). For CFSE labeling, 
5   ×   10  7   purifi  ed B cells/ml were loaded with 5   μ  M CFSE (Invitrogen) before 
culturing 2   ×   10  6   cells/ml with anti-IgM and anti-IgM F(ab    )  2   molecules. 
The extent of CFSE labeling was analyzed by fl  ow cytometry. 
  Western blot analysis 
  Standard Western blot analysis was performed using anti-V5  –  horseradish 
peroxidase (HRP) conjugate (Invitrogen) and chemiluminescent detection. 
Blots were stripped and reprobed with a     -actin  –  specifi  c antibody (Abcam) 
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instructions. Mouse serum, starting at 1:40 in PBS, was titrated across the 
slide. Slides were incubated for 30 min at room temperature and washed 
twice with PBS. Alexa Fluor 488  –  conjugated rabbit anti  –  mouse IgG anti-
body was added to the wells at 1:150 in PBS for 30 min at room tempera-
ture. After two more washes, slides were mounted on coverslips for blinded 
fl  uorescence microscopic analysis. 
  Phagocytosis and infection studies with   S. pneumoniae   
  For phagocytosis assays,   S. pneumoniae   type 2 (D39; provided by J. Brown, 
University College London, London, UK) was cultured to log phase in 
Todd-Hewitt broth with 0.5% yeast extract (Oxoid Ltd.), heat inactivated at 
60  °  C for 1 h, and labeled with Alexa Fluor 488 (Invitrogen) (  18, 56  ). Alexa 
Fluor 488  –  labeled   S. pneumoniae   were incubated in PBS or heat-inactivated 
immune serum at 37  °  C for 1 h before washing. Immune serum for opsoniza-
tion was obtained from mice immunized with pneumovax (Aventis-Pasteur 
MSD). Serum-opsonized and nonopsonized Alexa Fluor 488  –  labeled pneu-
mococci were added to plastic-adhered peritoneal macrophages at 37  °  C (and 
at 4  °  C as a control). Adhered macrophages were washed, harvested, and ana-
lyzed by fl  ow cytometry. Peritoneal macrophages were identifi  ed by scatter 
characteristics and CD11b  +   F4/80  +   staining. The percentage and geometric 
mean fl  uorescence of Alexa Fluor 488  +   macrophages were used as measures 
of phagocytosis. For infection studies, groups of 7  –  14 B-TG or M-TG mice 
and littermate NTG controls were inoculated intraperitoneally with 200   μ  l 
PBS containing between 3   ×   10  1   and 10  7   CFU   S. pneumoniae  , or intranasally 
with 50   μ  l PBS containing 2   ×   10  6   CFU   S. pneumoniae  . The development of 
disease was monitored as previously described (  57  ). During observation, 
mice were scored by a blinded observer for the presence or absence of physi-
cal signs of progressive sepsis. Mice that became moribund were considered 
to have reached the end point of the experiment and were killed. Survival 
data were analyzed using Kaplan-Meier graphs and log-rank tests. 
  Online supplemental material 
  Fig. S1 shows transgene expression in two independent strains of B-TG 
mice. Fig. S2 demonstrates no transgene expression on CD11b  +  , CD11c  +  , 
or CD3  +   cells in the B-TG line. Fig. S3 shows transgenic Fc    RIIb expres-
sion in spleens of B-TG mice by immunohistology. Fig. S4 demonstrates 
decreased Fc-mediated proliferation in B-TG B cells, and quantifi  cation 
of pERK measurements shown in   Fig. 2 C  . Fig. S5 shows that transgene 
expression is restricted to macrophages in two strains of M-TG mice. 
Fig. S6 shows no transgene expression on dendritic cells and FDCs in M-TG 
mice. Fig. S7 shows T-independent and T-dependent immune responses 
in M-TG mice. Fig. S8 shows levels of anti-CII IgG isotypes during CIA. 
Fig. S9 shows levels of natural anti-PC antibody. Table S1 shows abso-
lute cell numbers of various cell populations in B-TG and B-NTG mice. 
Table S2 shows absolute cell numbers of various cell populations in M-TG 
and M-NTG mice. Table S3 lists the primers used for the MRL/  lpr   back-
cross. Supplemental discussion discusses the transgenic expression profi  le in 
B-TG mice. Online supplemental material is available at http://www.jem.org/
cgi/content/full/jem.20072565/DC1. 
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